ATE201591T1 - Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen - Google Patents

Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen

Info

Publication number
ATE201591T1
ATE201591T1 AT96111163T AT96111163T ATE201591T1 AT E201591 T1 ATE201591 T1 AT E201591T1 AT 96111163 T AT96111163 T AT 96111163T AT 96111163 T AT96111163 T AT 96111163T AT E201591 T1 ATE201591 T1 AT E201591T1
Authority
AT
Austria
Prior art keywords
perfluoropolyethers
prevention
compositions
treatment
viral infections
Prior art date
Application number
AT96111163T
Other languages
English (en)
Inventor
Morris A Mann
Giovanni Pantini
Original Assignee
Morris A Mann
Ausimont Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI961070 external-priority patent/IT1282748B1/it
Application filed by Morris A Mann, Ausimont Spa filed Critical Morris A Mann
Application granted granted Critical
Publication of ATE201591T1 publication Critical patent/ATE201591T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyethers (AREA)
AT96111163T 1995-08-22 1996-07-11 Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen ATE201591T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US266595P 1995-08-22 1995-08-22
ITMI961070 IT1282748B1 (it) 1996-05-28 1996-05-28 Prevenzione e trattamento delle infezioni virali topiche con perfluoropolieteri o loro composizioni.

Publications (1)

Publication Number Publication Date
ATE201591T1 true ATE201591T1 (de) 2001-06-15

Family

ID=26331394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96111163T ATE201591T1 (de) 1995-08-22 1996-07-11 Vorbeugung und behandlung von topischen viralen infektionen mit perfluoropolyäthern oder deren zusammensetzungen

Country Status (10)

Country Link
US (1) US5719194A (de)
EP (1) EP0759301B1 (de)
JP (1) JPH09136838A (de)
KR (1) KR100420260B1 (de)
AT (1) ATE201591T1 (de)
AU (1) AU706952B2 (de)
CA (1) CA2183804A1 (de)
DE (1) DE69613058T2 (de)
MX (1) MX9603596A (de)
TW (1) TW415844B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US7033500B2 (en) * 2001-06-25 2006-04-25 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
WO2003000373A1 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Systems and methods using a solvent for the removal of lipids from fluids
US20030127386A1 (en) * 2001-06-25 2003-07-10 Bomberger David C. Hollow fiber contactor systems for removal of lipids from fluids
AU2003268190B2 (en) * 2002-08-26 2008-04-03 Eli Lilly And Company Treating Alzheimers using delipidated protein particles
JP2007527387A (ja) * 2003-07-03 2007-09-27 リピッド サイエンシーズ，インコーポレイテッド 脂質含量の低下したｈｄｌの粒子誘導体を製造するための方法及び装置
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
CN102333851B (zh) * 2009-02-27 2016-06-15 Ntn株式会社 润滑脂组合物、润滑脂封入轴承、推进器轴用万向联轴器、润滑油组合物及烧结含油轴承
WO2014130432A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
WO2019104237A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
EP3731814A4 (de) 2017-12-28 2021-09-29 HDL Therapeutics, Inc. Verfahren zur konservierung und verabreichung von aus menschlichem plasma extrahiertem prä-beta-lipoprotein hoher dichte
RU2697886C1 (ru) * 2018-08-06 2019-08-21 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Противовирусная композиция
RU2697887C1 (ru) * 2018-08-06 2019-08-21 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Средство, обладающее противовирусным действием в отношении вирусов клещевого энцефалита и герпеса простого I типа

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897502A (en) * 1971-10-22 1975-07-29 Airco Inc Process for making fluorinated ethers
IT1183530B (it) * 1985-03-29 1987-10-22 Monteluos S P A Composizioni per cosmesi comprendente perfluoropolieteri
IL82308A (en) * 1986-06-26 1990-11-29 Ausimont Spa Microemulsions containing perfluoropolyethers
IT1229222B (it) * 1989-03-31 1991-07-26 Ausimont Srl Emulsioni stabili di perfluoropolieteri
IT1244032B (it) * 1990-12-18 1994-06-28 Ausimont Spa Emulsioni stabili di perfluoropolieteri e sostanze grasse e processo per la loro preparazione

Also Published As

Publication number Publication date
JPH09136838A (ja) 1997-05-27
DE69613058D1 (de) 2001-07-05
AU6218996A (en) 1997-03-13
DE69613058T2 (de) 2002-03-07
KR970009797A (ko) 1997-03-27
KR100420260B1 (ko) 2004-06-04
AU706952B2 (en) 1999-07-01
US5719194A (en) 1998-02-17
MX9603596A (es) 1997-06-28
EP0759301B1 (de) 2001-05-30
EP0759301A2 (de) 1997-02-26
TW415844B (en) 2000-12-21
CA2183804A1 (en) 1997-02-23
EP0759301A3 (de) 1997-10-01

Similar Documents

Publication Publication Date Title
DE69613058D1 (de) Vorbeugung und Behandlung von topischen viralen Infektionen mit Perfluoropolyäthern oder deren Zusammensetzungen
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
DE69101922D1 (de) Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
DK0445255T4 (da) Anvendelse af hyaluronsyre i kombination med ascorbinsyre, antitumormidler og/eller NSAID's til behandling af cancer
ATE183638T1 (de) Festes produkt zur behandlung von xerostomie
DK0574457T3 (da) Antiviral nucleosidkombination
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
TR199901754T2 (xx) Helicobacter pylori enfeksiyonlar�n�n ve bunlarla ba�lant�l� gastro-duodenal rahats�zl�klar�n tedavisinde
EP1001782A4 (de) 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DE69300806D1 (de) Lackhilfsmittel und wasserverdünnbare Farbzusammensetzung.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
OA09917A (en) Compounds for use in treating HIV infection
PH25224A (en) Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
FI944933A7 (fi) 7-disubstitoitu metyyli-4-okso-3H,5H-pyrrolo(3,2-d) pyrimidiini ja sit ä sisältäviä farmaseuttisia käyttöjä ja koostumuksia
DE69220939D1 (de) Gegengift immunsera
TR199802270A2 (xx) S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri.
DE68914454D1 (de) Pharmazeutische zusammensetzungen und deren verwendung in der behandlung von entzündungen.
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
DK24687D0 (da) 3-alkoxyflavonderivater samt antiviralt virksomme terapeutiske midler indeholdende disse
FI954213A7 (fi) Kasvainten vastaisia koostumuksia ja hoitomenetelmiä

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties